Metal vs Carbon-Fibre Implants in Bone Cancer Surgery

by Jazzmin Huber | Nov 29, 2022 | Research

To treat osteosarcoma (OS), surgeons will often remove the bone containing the tumour. This bone can then be replaced with a metal implant. A recent study looked at whether implants made of carbon-fibre could be an alternative to metal. Metal Implants Metal is the...

Testing Existing Drugs in Osteosarcoma Models

by Katie Nightingale | Nov 22, 2022 | Research

There is an urgent need to find new therapies in osteosarcoma (OS) that has spread or has not responded to standard treatment. Identifying new treatments can be a long and complex process. One method of speeding up the process is to use drugs that already approved to...

Using 3D Bioprinting to Study Osteosarcoma

by Katie Nightingale | Nov 15, 2022 | Research

There is a great need to develop new treatments for osteosarcoma (OS). This is particularly true for OS that has spread or has not responded to current standard therapy. Researchers are actively working towards finding new drugs to treat OS. To enable the drug...

Help Direct Bone Cancer Research

by Jazzmin Huber | Nov 8, 2022 | Research, Resources and Support

The first ever global survey for bone cancer patients and carers has been launched. The aim of the survey is to understand the patient experience and advance research into bone cancer. It was created by parents and patients as part of FOSTER (Fighting OSteosarcoma...

3D Printing in Bone Cancer Surgery

by Jazzmin Huber | Nov 1, 2022 | Research

Surgeons are developing new techniques to aid them in removing bone cancer. One of these techniques is printing personalised 3D models of tumours to guide the surgery. Bone cancers are a group of cancers that include osteosarcoma (OS). The treatment for these cancers...

Fighting Osteosarcoma Through Research Together

by Jazzmin Huber | Oct 25, 2022 | Clinical Trials, Research

This October clinicians, researchers and patient advocates from across Europe came together for the first in-person FOSTER (Fighting OSteosarcoma Through European Research) meeting. The event was held over two days at the Gustave Roussy Cancer Research hospital in...